A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast ...

Blood-based markers that could improve early, less invasive detection of inflammatory breast cancer, or IBC, were identified by researchers at University of Hawaiʻi Cancer Center. The discovery — ...

Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general. IBC ...

Houston – October marks Breast Cancer Awareness Month when conversations surround detection and screenings. There is one form of breast cancer that doesn’t come up in conversations—Inflammatory Breast ...

By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss ...

SAN ANTONIO — Guideline-concordant care is associated with improved overall survival in patients with inflammatory breast cancer. Yet, a retrospective study of patients with inflammatory breast ...

New IBC diagnosis codes, effective October 1, 2025, will improve documentation, expedite treatment, and support research efforts. IBC is aggressive and often misdiagnosed due to atypical symptoms, ...

Inflammatory breast cancer (IBC) is highly aggressive, but extremely difficult to tell apart from other breast cancers. Researchers at The University of Texas at Austin and The University of Texas MD ...

With one in every eight women diagnosed with breast cancer at some point in their lives, experts agree that early detection and treatment is key. "One of the biggest goals when it comes to breast ...